KIRSCH ARTHUR S has filed 5 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 37960 shares of Evommune, Inc. ($EVMN) on November 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 5, 2025 | Evommune, Inc. | $EVMN | KIRSCH ARTHUR S | Not found | A | Stock Option (Right to Buy) | 37960 | $0.00 | 37,960.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2025 | Liquidia Corp | $LQDA | Kirsch Arthur S | Director | A | Common Stock | 18396 | $0.00 | 70,755.0000 | 85,172,696 | 35.13% | 0.02% |
| Feb. 20, 2025 | Atea Pharmaceuticals, Inc. | $AVIR | Kirsch Arthur S | Not found | A | Stock Option (Right to Buy) | 164800 | $0.00 | 164,800.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Liquidia Corp | $LQDA | Kirsch Arthur S | Director | A | Common Stock | 20359 | $0.00 | 52,359.0000 | 75,393,907 | 63.62% | 0.03% |
| June 19, 2023 | Liquidia Corp | $LQDA | Kirsch Arthur S | Director | A | Non-Qualified Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 64,656,424 | 9999.99% | 0.03% |